Meeder Advisory Services Inc. Sells 1,195 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Meeder Advisory Services Inc. trimmed its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 4.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,454 shares of the pharmacy operator’s stock after selling 1,195 shares during the period. Meeder Advisory Services Inc.’s holdings in Walgreens Boots Alliance were worth $273,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Colonial Trust Co SC raised its position in shares of Walgreens Boots Alliance by 79.5% in the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator’s stock valued at $27,000 after purchasing an additional 1,297 shares during the last quarter. Sentry Investment Management LLC purchased a new position in shares of Walgreens Boots Alliance in the 1st quarter valued at approximately $27,000. Curat Global LLC purchased a new position in shares of Walgreens Boots Alliance in the 1st quarter valued at approximately $27,000. Vestor Capital LLC purchased a new position in shares of Walgreens Boots Alliance in the 1st quarter valued at approximately $45,000. Finally, Central Pacific Bank Trust Division raised its position in shares of Walgreens Boots Alliance by 28.6% in the 1st quarter. Central Pacific Bank Trust Division now owns 4,500 shares of the pharmacy operator’s stock valued at $50,000 after purchasing an additional 1,000 shares during the last quarter. 58.59% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ:WBA opened at $11.64 on Friday. The firm has a market capitalization of $10.08 billion, a PE ratio of -1.60, a price-to-earnings-growth ratio of 1.37 and a beta of 0.80. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $13.25. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.60 and a quick ratio of 0.32. The firm’s 50-day moving average is $11.43 and its two-hundred day moving average is $11.12.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.34 by $0.04. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The company had revenue of $38.99 billion during the quarter, compared to the consensus estimate of $36.72 billion. During the same quarter in the previous year, the firm earned $0.63 earnings per share. The firm’s quarterly revenue was up 7.2% on a year-over-year basis. Analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the stock. Wall Street Zen assumed coverage on shares of Walgreens Boots Alliance in a research report on Wednesday, May 21st. They set a “hold” rating for the company. UBS Group reaffirmed a “neutral” rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. Finally, Morgan Stanley reaffirmed an “underweight” rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $10.59.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.